Cite
APA Citation
Humrich, J. Y., von Spee-Mayer, C., Siegert, E., Bertolo, M., Rose, A., Abdirama, D., Enghard, P., Stuhlmüller, B., Sawitzki, B., Huscher, D., Hiepe, F., Alexander, T., Feist, E., Radbruch, A., Burmester, G., & Riemekasten, G. (2019). low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial. Lancet, 1, e44–e54. http://access.bl.uk/ark:/81055/vdc_100101587896.0x000001